Article Image
IPFS News Link • Microchipping

Microchips, Nanotechnology and Implanted Biosensors: The New Normal?

•, By Pam Long

Profusa has research contracts for bio-integrated sensors with the U.S. Department of Defense and Defense Advanced Research Projects Agency (DARPA), pending U.S. Food and Drug Administration approval in early 2021.

Health technology undermines freedom and privacy
Profusa's promotional video shows how the bio-integrated sensor enables a soldier to be tracked by remote computers using GPS in addition to monitoring real-time biomarkers, such as oxygen levels and heart rate. While this biotechnology is portrayed as potentially lifesaving to a soldier on the battlefield, the implications of GPS tracking individuals is a terrifying step towards a surveillance state in the general population. Furthermore, tracking people in stages of sickness can only result in medical tyranny in the hands of any government. The Profusa influenza study requires patients to wear the wearable version of the reader 24 hours a day, with continuous biomarker information collection into a database, and aims to detect four stages of infection: healthy, infected, asymptomatic and recovery stage. These unreliable detection stages could become the criteria for different levels of individual participation in society as experienced in the unsustainable COVID-19 state-level lockdowns for the masses.

Can it be reversed? Can it be refused?
This Profusa nanotechnology has three components: an inserted sensor called hydrogel, a light-emitting fluorescent sensor reader on the surface of the skin and an electronic software component that transmits to an online database. The SARS-CoV-2 vaccine plans to incorporate this technology and there is no information on how the technology could be removed, if at all. "Tiny biosensors that become one with the body" could imply a lifetime commitment.